Soleus Capital Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
+730,000
| New | +$3.74M | 0.25% | 62 |
|
|
2024
Q4 | – | Sell |
-343,152
| Closed | -$2.64M | – | 106 |
|
|
2024
Q3 | $2.64M | Sell |
343,152
-706,743
| -67% | -$5.44M | 0.2% | 72 |
|
|
2024
Q2 | $9.01M | Sell |
1,049,895
-300,250
| -22% | -$2.58M | 0.79% | 41 |
|
|
2024
Q1 | $10.7M | Buy |
1,350,145
+503,000
| +59% | +$3.99M | 0.8% | 35 |
|
|
2023
Q4 | $8.39M | Sell |
847,145
-1,081,874
| -56% | -$10.7M | 0.93% | 34 |
|
|
2023
Q3 | $21.7M | Buy |
1,929,019
+152,122
| +9% | +$1.71M | 2% | 14 |
|
|
2023
Q2 | $5.9M | Buy |
+1,776,897
| New | +$5.9M | 0.66% | 45 |
|